Drug sensitivity analysis suggested that high expression levels of IFIT1 in melanoma are associated with increased sensitivity to the tyrosine kinase inhibitor, dasatinib and positively correlated with the level of immune cell infiltrates and markers [20]. Here, IFIT1 is linked to melanoma.